Former Kodak Division Becomes Truesense Imaging

David Rosenfeld | | Radiology Business | Business Intelligence
A former division of Kodak purchased by Platinum Equity in November has been revamped as Truesense Imaging. The company will continue to provide image sensor devices for digital cameras, surveillance, scientific devices and medical imaging as it did under Kodak’s Image Sensor Solutions division, based on an article at Cnet.com. "As an independent company, we now have a great opportunity to expand our leadership position and to grow into new markets and new applications that leverage our core strengths in imaging technology," Chris McNiffe, Truesense's CEO and former general manager of Kodak's image-sensor business, said in a statement. "This is a very positive step forward for our business, our employees and, of course, our customers."

David Rosenfeld

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.